In honor of Cystic Fibrosis Awareness Month, we present a 2-part series on treatment updates and developments in the field.
All articles by Tori Rodriguez, MA, LPC, AHC
In honor of Cystic Fibrosis Awareness Month, we present a 2-part series on treatment updates in the field, including the “sweat sticker.”
Although it has become widely accepted that COPD encompasses a range of phenotypes, the development of a precision medicine approach has been slow.
The gains in the global fight against tuberculosis have been threatened as a result of the COVID-19 pandemic, including a diversion of resources that have led to disruptions in ongoing research and control programs.
MeiLan K. Han, MD, and Paul Enright, MD, share their opposing perspectives on the necessity and utility of defining “pre-COPD” in at-risk patients.
Mask-related side effects have been cited as the most important factor influencing adherence to continuous positive airway pressure (CPAP) therapy.
Consumer e-cigarette use has reversed some of the gains in public health efforts against smoking and increased rates of nicotine consumption.
Along with a wide range of elective medical services affected by the COVID-19 crisis, pulmonary screenings decreased substantially, especially in the early months of the pandemic.
In part 3 of this series, we interviewed Samuel Cykert, MD, who helped build a system-based intervention to reduce racial gaps and improve care for all patients with lung cancer.
In part 2 of this 3-part series, the recent State of Lung Cancer report by the American Lung Association, which included state-level and national-level data on lung cancer in people of color for the first time.
A sizable body of research has long shown racial disparities in treatment and survival between Black and White patients with lung cancer.
The National Asthma Education and Prevention Program published focused updates to their asthma management guidelines.
A growing number of studies involve the role of prone positioning to improve ventilation in patients with acute respiratory distress syndrome (ARDS) related to COVID-19.
The 6th WSPH Task Force on Hemodynamic Definitions and Clinical Classification recently proposed reducing the diagnostic mPAP threshold for pulmonary hypertension.
While cardiopulmonary exercise testing is commonly used to identify exercise-induced bronchoconstriction in asthma, this approach may also prove useful in assessing additional measures of functioning and treatment response.
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
There may be interactive health effects between the 2 crises of the COVID-19 pandemic and US wildfires.
Findings suggest lower rates of COVID-19 infection and mortality in countries with universal neonatal BCG tuberculosis vaccination policies compared with countries without this practice.
As a central goal of PF Awareness Month and their ongoing work, the Pulmonary Fibrosis Foundation aims to improve diagnostic delays and misdiagnoses in this patient population.
Artificial intelligence has the potential to ease the workload of physicians while increasing the speed and accuracy of diagnosis, particularly in pulmonology.
In the midst of the COVID-19 pandemic, patients with lung cancer face an increased risk of disease progression, reduced survival, and worse quality of life associated with delayed treatment.
PAH associated with CHD is linked to significant reductions in survival and quality of life, especially for patients progressing to Eisenmenger syndrome.
Obstructive sleep apnea may represent another important variable contributing to increased risk related to COVID-19.
Individuals with pulmonary fibrosis could develop more serious complications if infected with COVID-19, and those awaiting organ transplantation and other surgical interventions may face delays because of the pandemic.
Although pulmonary hypertension as a result of interstitial lung disease is linked to significant morbidity and mortality, there is no consensus regarding screening or management of the disease.
Recent studies have led to important insights regarding the role of viruses in asthma pathogenesis and exacerbations, as well as mediating factors involved in these processes.
Patients with COVID-19 who also have poor baseline health and/or obesity are more likely to demonstrate impaired respiratory muscle performance.
Clinicians have proposed a system-wide response plan for the delivery of high-quality palliative care across a continuum of conventional, contingency, and crisis capacity scenarios during the COVID-19 pandemic.
Despite significant advances in asthma treatment in the past decades, the disease is still poorly controlled in an estimated 50% of patients.
Physicians and hospitals have urged the public to seek immediate medical care when needed, with reassurance regarding sound infection control practices that hospitals have implemented in light of the COVID-19 pandemic.
Latest News Your top articles for ThursdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses